AFT Pharmaceuticals raises $9.1M via redeemable share issue, announces SPP

Rebecca Howard
Thu, 16 Mar 2017

By Rebecca Howard March 17 (BusinessDesk) - AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, raised new funds through a redeemable share issue to fuel international growth and announced plans to raise more capital in a share purchase plan. The Auckland-based drug maker said the redeemable share issue raised approximately $9.1 million from CRG, a US health-care investor, and the Atkinson Family Trust at $2.74 per share, equal to the volume weighted average price of AFT's ordinary shares on the NZX over the last five busin...

Unlock all stories
free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
Comprehensive business and markets coverage
News via email, web and Apple/Android apps

Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Find out more

Subscribe now

Name

E-Mail Address

Password

Confirm Password

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Cardholder's Name

Card

You will be charged in 10 days unless you cancel beforehand. We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service {{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Or Subscribe with Google

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Property

A 'reasonably difficult' thorn in Thiel’s Wānaka site

Brent Melville | Wed, 25 May 2022

Whether Peter Thiel's rich lister lodge falls within the 'visual requirements' for an outstanding natural landscape has become the central theme in his battle with the local authority.

Economy

RBNZ raises rates by 50 basis points to 2.0%

Rebecca Howard | Wed, 25 May 2022

The central bank sees the OCR peaking at 3.9% in June 2023 but then easing back to 3.5%

The Quiz FREE

QuiznessDesk, Wednesday, May 25, 2022

The Quizmaster | Wed, 25 May 2022

This chilly weather is the perfect time for you to test your smarts in our daily quiz. Good luck!

Partner content

Small business lessons for attracting and retaining staff

Employers battling through the ‘Great Resignation’ are now faced with the ‘Great Brain Drain’.

Partner content

People leaders are key to wellbeing but still need help

One in three people say they have experienced an issue with an unsupportive manager

AFT Pharmaceuticals raises $9.1M via redeemable share issue, announces SPP

Subscribe now

Or Subscribe with Google

Not convinced yet?

Your company has a subscription

Team